EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report

Xia Zou, Kun Wang, Rui Zeng

American Journal of Case Reports · 2025

DOI: 10.12659/ajcr.948890 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Case Reports, 2025. Verfasst von Xia Zou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious …. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Kidney Tubules, Proximal, Kidney Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Light chain proximal tubulopathy (LCPT) is a rare monoclonal immunoglobulin light chain-associated kidney disease. A few clinical case reports have shown that lenalidomide is an effective treatment for LCPT. Daratumumab, an anti-CD38 monoclonal antibody, has demonstrated efficacy in multiple myeloma and light chain amyloidosis, with good hematologic and organ response. However, the role of daratumumab in non-amyloid monoclonal gammopathy of renal significance requires further validation. CASE REPORT This report describes a case of LCPT that was unresponsive to lenalidomide but responded favorably to a daratumumab-based regimen. A middle-aged man presented with fatigue, nocturia, and hypokalemia as initial symptoms upon admission. Auxiliary examinations indicated renal dysfunction, without proteinuria. During the evaluation of secondary causes of renal dysfunction, serum immunofixation electrophoresis detected an IgA-Kappa-type M proteinemia, prompting a bone marrow aspiration for definitive diagnosis, which revealed 3% immature plasma cells. Finally, LCPT was diagnosed based on renal biopsy. After the diagnosis of the disease, early treatment with lenalidomide was not effective. However, after 5 cycles of treatment with daratumumab and dexamethasone, and a subsequent 2 cycles of daratumumab, bortezomib, cyclophosphamide, and dexamethasone (Dara-CyborD), the patient's clinical symptoms were completely relieved, blood potassium levels normalized, serum creatinine levels decreased 50%, and hematological remission was completely achieved. CONCLUSIONS Early diagnosis of LCPT, a rare monoclonal immunoglobulin disorder, has become increasingly feasible with advances in histopathological evaluation and hematological testing. This report shows that a daratumumab-based regimen or Dara-CyborD can offer a novel therapeutic strategy for the treatment of LCPT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalKidney Tubules, ProximalKidney DiseasesHumansMaleMiddle AgedRemission InductionDexamethasoneImmunoglobulin Light ChainsBortezomib

Substanzen

daratumumabAntibodies, MonoclonalDexamethasoneImmunoglobulin Light ChainsBortezomib

Autor:innen und Institutionen

  • Department of Nephrology, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, Hubei,…
  • Division of Nephrology, Department of Internal Medicine, Zhongxiang People's Hospital, Zhongxiang, Hubei, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei, China.

Zitieren

APA

Zou, X., Wang, K., & Zeng, R. (2025). Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report. American Journal of Case Reports. https://doi.org/10.12659/ajcr.948890

Vancouver

Zou X, Wang K, Zeng R. Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report. American Journal of Case Reports. 2025. doi:10.12659/ajcr.948890

BibTeX
@article{Zou2025,
  author = {Zou, Xia and Wang, Kun and Zeng, Rui},
  title = {Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report},
  journal = {American Journal of Case Reports},
  year = {2025},
  doi = {10.12659/ajcr.948890}
}
Kostenlos starten →